Little Green Pharma kicks off WA based psychedelic mental health trial
Little Green Pharma positions itself for growth in France’s emerging medicinal cannabis market
Little Green Pharma kicks off prospectus offer for psychedelic spin-out
Little Green Pharma posts 30pc increase in revenue and 50pc rise in cash receipts for September quarter
LGP subsidiary Reset Mind Sciences, enters into a world first, strategic partnership to establish a mental health treatment facility
Little Green Pharma CEO & CEO of Reset Mind Sciences welcome TGA decision on psychedelic prescriptions
Little Green Pharma (ASX:LGP) and subsidiary welcome TGA psychedelics ruling
Little Green Pharma (ASX:LGP) reflects on a record 12 months
Little Green Pharma’s (ASX:LGP) - A brief history from CEO
Little Green Pharma wins at Australian Export Awards 2022
LGP continues EUR expansion w/ Denmark acquisition
LGP continues European expansion with DEMECAN order